Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 31.08.2026 2 Acta Ophthalmol 3 Am J Manag Care 2 Am J Med 2 Am J Nephrol 2 Am J Ophthalmol 1 Biochem Biophys Res Commun 1 BMC Ophthalmol 1 Circulation 6 Diabet Med 1 Diabetes 8 Diabetes Care 27 Diabetes Obes Metab 3 Diabetologia 1 J Am Coll Cardiol 1 J Am Soc Nephrol 1 J Biol Chem 3 J Diabetes Complications 1 J Hypertens 2 Kidney Int 1 Metabolism 1 PLoS Med 5 PLoS One 3 Retina 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Ophthalmol

1. GRONLYKKE L, Wiberg S, Carter A, Ratgen PH, et al
   Grading-labour cost analysis of AI-assisted versus human-only diabetic retinopathy screening in two Danish healthcare settings.
   Acta Ophthalmol. 2026 Aug 22. doi: 10.1111/aos.70225.
   PubMed         Abstract available
   
   
2. LOWATER SJE, Nunez AB, Andersen JKH, Dinesen S, et al
   Evaluation of spatial distribution of initial marking strategy among inexperienced graders in diabetic retinopathy: A retrospective cross-sectional analysis.
   Acta Ophthalmol. 2026 Aug 27. doi: 10.1111/aos.70224.
   PubMed         Abstract available
   
   

   
   Am J Manag Care

3. MARTENS TW, Patel BV, Wang SM, Messer LH, et al
   Impact of Automated Insulin Delivery on Type 2 Diabetes Measures.
   Am J Manag Care. 2026;32:e222-e227.
   PubMed         Abstract available
   
   
4. SISODIA A
   Predicting GLP-1 Discontinuation From Pharmacy Claims.
   Am J Manag Care. 2026;32:426-428.
   PubMed         Abstract available
   
   
5. ROMINE J, Chi W, Essel K, Mullikin R, et al
   Insurance-Provided Grocery Assistance and Health Care Outcomes Among Patients With Diabetes.
   Am J Manag Care. 2026;32:e280-e285.
   PubMed         Abstract available
   
   

   
   Am J Med

6. WU J, Zhao R, Ma Y, Chen Y, et al
   Examining Sleep Quality and Mortality Risks in COPD, Asthma, and Asthma-COPD Overlap Patients.
   Am J Med. 2026 May 11:S0002-9343(26)00378-5. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   
7. RAO AK, Ibrahim A, Rockey DC
   The effect of SGLT-2 inhibitors on portal hypertensive complications and mortality in patients with cirrhosis.
   Am J Med. 2026 Apr 17:S0002-9343(26)00294-9. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   

   
   Am J Nephrol

8. TWAL WO, Angel PM, Helke KL, Awgulewitsch A, et al
   Hyperglycemia and alteration in sphingolipids are early mediators of diabetic kidney disease: role of elongase 1 (Elovl1).
   Am J Nephrol. 2026 Aug 28:1-30. doi: 10.1159/000552867.
   PubMed         Abstract available
   
   
9. MAYHAND KN, Zemke A, Alicic R, Kornowske LM, et al
   Risks of Major Adverse Kidney Events in Non-Hispanic Black Patients with Diabetes or Hypertension: A real-world cohort study.
   Am J Nephrol. 2026 Aug 28:1. doi: 10.1159.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

10. RAMSEY DJ
    Response to Comment on "Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy".
    Am J Ophthalmol. 2026 Aug 24:S0002-9394(26)00479.
    PubMed        
    
    
11. WANG J
    Comment on: "Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients With Type 2 Diabetes and Diabetic Retinopathy".
    Am J Ophthalmol. 2026 Aug 22:S0002-9394(26)00478.
    PubMed        
    
    

    
    Biochem Biophys Res Commun

12. ULLAH F, Ali H
    Non-coding RNAs in diabetic cardiomyopathy: Mechanistic insights, diagnostic and prognostic potential, and therapeutic perspectives.
    Biochem Biophys Res Commun. 2026;834:154514.
    PubMed         Abstract available
    
    

    
    BMC Ophthalmol

13. ALSHABIB N, Alarfaj M, Albahlal A, Alyousif NA, et al
    Sympathetic ophthalmia complicating proliferative diabetic retinopathy: diagnostic and therapeutic challenges during pregnancy.
    BMC Ophthalmol. 2026;26:514.
    PubMed         Abstract available
    
    

    
    Circulation

14. DAI Y, Li Q, Ding F, Chen S, et al
    Site-Specific Apo AI Glycation Impairs HDL Function and Promotes Atherosclerosis in Diabetes.
    Circulation. 2026 Aug 25. doi: 10.1161/CIRCULATIONAHA.125.078171.
    PubMed         Abstract available
    
    

    
    Diabet Med

15. DESAI SS, Malik MMUD
    Comment on 'Improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro) insulin autoantibodies'.
    Diabet Med. 2026 Aug 28:e70462. doi: 10.1111/dme.70462.
    PubMed        
    
    
16. WYATT RC, Brigatti C, Grace SL, Williams CL, et al
    In response to comment on improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro) insulin autoantibodies.
    Diabet Med. 2026 Aug 28:e70471. doi: 10.1111/dme.70471.
    PubMed        
    
    
17. OZER H, Demir HI, Coban S, Atay G, et al
    Renal outcomes following fundus fluorescein angiography in patients with diabetic nephropathy: Incidence, risk factors and three-month kidney function changes.
    Diabet Med. 2026 Aug 27:e70455. doi: 10.1111/dme.70455.
    PubMed         Abstract available
    
    
18. BULLOCK A
    The impact of frailty on glycaemic control in older adults with type 1 diabetes: An observational study.
    Diabet Med. 2026 Aug 26:e70460. doi: 10.1111/dme.70460.
    PubMed        
    
    
19. GOLDING J, Hamilton-Evans P, Marlow V, Lipscomb D, et al
    Addressing the landscape of diabetes care within community nursing: Learning from a Sussex-based service evaluation.
    Diabet Med. 2026 Aug 24:e70467. doi: 10.1111/dme.70467.
    PubMed         Abstract available
    
    
20. BLACK R, Hasson F, King L, Davies M, et al
    Impact of diabetes mellitus on the menopausal experience: A scoping review.
    Diabet Med. 2026 Aug 22:e70420. doi: 10.1111/dme.70420.
    PubMed         Abstract available
    
    

    
    Diabetes

21. NICODEMO JL, Makri A, Polychronakos C
    What Proportion of Antibody-Negative Type 1 Diabetes Cases Have a Nonautoimmune Etiology? A Genetics-Based Estimate.
    Diabetes. 2026 Aug 24:db251110. doi: 10.2337/db25-1110.
    PubMed         Abstract available
    
    

    
    Diabetes Care

22. JI L, Ma J, Cheng Z, Liu D, et al
    A Randomized Placebo-Controlled Trial of HTD1801 Monotherapy in Participants With Type 2 Diabetes.
    Diabetes Care. 2026 Aug 24:dc260739. doi: 10.2337/dc26-0739.
    PubMed         Abstract available
    
    
23. DUN C, Fang M, Wang D, Hettinger G, et al
    State-Level Variation in GLP-1 Receptor Agonist Use Among Medicaid Beneficiaries Without Diabetes by State Obesity Coverage Policy.
    Diabetes Care. 2026 Aug 24:dc261511. doi: 10.2337/dc26-1511.
    PubMed        
    
    
24. KALYON O, Arumugam R, Patel D, Wright S, et al
    Incorporating mtDNA Structural Variant Analysis Into Routine Genome Sequencing Increases Monogenic Diabetes Diagnosis at No Additional Cost.
    Diabetes Care. 2026 Aug 25:dc261211. doi: 10.2337/dc26-1211.
    PubMed        
    
    
25. WU X, Zu Y, Lu Y, Zhao Y, et al
    The Joint Effects of Life's Essential 8 and Genetics on Mild Cognitive Impairment and Dementia Risk in People With Diabetes: Findings From the UK Biobank and All of Us.
    Diabetes Care. 2026 Aug 27:dc253126. doi: 10.2337/dc25-3126.
    PubMed         Abstract available
    
    
26. DIB S, Kusinski LC, Powell R, Cole TJ, et al
    Third-Trimester Energy-Restriction or Weight Loss and Maternal and Child Body Composition One Year Postnatally After a Pregnancy With Gestational Diabetes: Results From the DiGest Follow-up Study.
    Diabetes Care. 2026 Aug 27:dc260405. doi: 10.2337/dc26-0405.
    PubMed         Abstract available
    
    
27. FANG M, Wang D, Rebholz CM, Echouffo-Tcheugui JB, et al
    Effects of the DASH4D Diet on Biomarkers of Glycemia in Adults With Type 2 Diabetes: A Secondary Analysis of the DASH4D Randomized Clinical Trial.
    Diabetes Care. 2026 Aug 28:dc261062. doi: 10.2337/dc26-1062.
    PubMed         Abstract available
    
    
28. ZHANG Y, Budhram D, Bapat P, Dhaliwal S, et al
    The Minimum Frequency of Well-Day Capillary Blood Ketone Testing Needed to Predict 1-Month Diabetic Ketoacidosis Risk in Type 1 Diabetes.
    Diabetes Care. 2026 Aug 28:dc261110. doi: 10.2337/dc26-1110.
    PubMed         Abstract available
    
    
29. OSTROMINSKI JW, Lu H, Claggett BL, Desai AS, et al
    Hypokalemia and New-Onset Diabetes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Diabetes Care. 2026 Aug 28:dc261305. doi: 10.2337/dc26-1305.
    PubMed        
    
    

    
    Diabetes Obes Metab

30. CHEN SC, Huang YN, Li PY, Chen JC, et al
    Cardiorenal Mortality and Safety Outcomes of GLP-1 Receptor Agonists in Type 2 Diabetes With BMI Below 27 kg/m(2): A Target Trial Emulation.
    Diabetes Obes Metab. 2026 Aug 25. doi: 10.1111/dom.71266.
    PubMed         Abstract available
    
    
31. LIAO J, Yuan Q, Xia Y
    Continuous Glucose Monitoring in Gestational Diabetes: Does More Treatment Translate to Better Outcomes?
    Diabetes Obes Metab. 2026 Aug 25. doi: 10.1111/dom.71282.
    PubMed        
    
    
32. DU J, Wu S, Wang Y, Liu M, et al
    Maternal Gestational Diabetes and Trajectories of Offspring Fat-Lean Balance in the Millennium Cohort Study.
    Diabetes Obes Metab. 2026 Aug 25. doi: 10.1111/dom.71260.
    PubMed         Abstract available
    
    
33. NARI F, Lee J, Kim J, Lim S, et al
    Effects of Sarpogrelate Versus Aspirin on Whole Blood Viscosity in Patients With Type 2 Diabetes and Peripheral Artery Disease.
    Diabetes Obes Metab. 2026 Aug 24. doi: 10.1111/dom.71265.
    PubMed         Abstract available
    
    
34. FORREST AS, Majety P, Mayer SB, Ganda OP, et al
    Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health.
    Diabetes Obes Metab. 2026 Aug 24. doi: 10.1111/dom.71180.
    PubMed         Abstract available
    
    
35. LIARAKOS AL, Idris I, Wilmot EG
    Priorities, Expectations, Perceptions of Time in Tight Range and Support Needs Relating to Closed-Loop Therapy Among Adults With Type 1 Diabetes: The SELECT HCL Study.
    Diabetes Obes Metab. 2026 Aug 24. doi: 10.1111/dom.71263.
    PubMed         Abstract available
    
    
36. GAO L, Guo Y, Cong X, Yang T, et al
    Cardiac Autonomic Markers Partly Account for Adiposity-Related Liver Enzyme Variation in Non-Diabetic Adults With Overweight or Obesity.
    Diabetes Obes Metab. 2026 Aug 24. doi: 10.1111/dom.71238.
    PubMed         Abstract available
    
    
37. WONG KTC, Yin JDC, Chan SCS, Wong NS, et al
    Multi-Dimensional Barriers for Work Productivity and Possible Solutions to Overcome Presenteeism in Young-Onset Diabetes: A Mixed-Methods Study.
    Diabetes Obes Metab. 2026 Aug 26. doi: 10.1111/dom.71158.
    PubMed         Abstract available
    
    
38. UPADHYAY N, Bonakdar A, Subedi K, Banerjee S, et al
    Trends in Cost of Care With Tirzepatide in Adults Aged Over 55 Years With Obesity or Overweight Without Diabetes: A Matched Cohort Analysis.
    Diabetes Obes Metab. 2026 Aug 24. doi: 10.1111/dom.71250.
    PubMed         Abstract available
    
    
39. PEREZ-LOPEZ P, Lopez-Gomez JJ, de la Calzada-Martinez A, Gonzalez-Gutierrez J, et al
    Intramuscular Fat Assessed by AI-Assisted Muscle Ultrasound: Association With Cardiometabolic Risk Factors and Diabetic Nephropathy in Diabetes Mellitus.
    Diabetes Obes Metab. 2026 Aug 24. doi: 10.1111/dom.71249.
    PubMed         Abstract available
    
    
40. SRIDHAR VS, Kugathasan L, Girard M, Davies MJ, et al
    Effect of Sotagliflozin on Kidney Function and Cardio-Kidney-Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD.
    Diabetes Obes Metab. 2026 Aug 24. doi: 10.1111/dom.71256.
    PubMed        
    
    
41. LIAO S, Sung GCY, Liang Y, Li C, et al
    Proteomic Pathways Linking Type 2 Diabetes Genetic Clusters to Cardiovascular Diseases: A Network Mendelian Randomisation Study.
    Diabetes Obes Metab. 2026 Aug 24. doi: 10.1111/dom.71253.
    PubMed         Abstract available
    
    
42. BARER Y, Schiller T, Nitecki M, Twig G, et al
    Glucose Challenge Test Values Within the Normal Range and Long-Term Risk of Type 2 Diabetes by Pre-Pregnancy BMI: A Retrospective Cohort Study.
    Diabetes Obes Metab. 2026 Aug 23. doi: 10.1111/dom.71259.
    PubMed         Abstract available
    
    
43. LE P, Guo N, Misra-Hebert A, Boyer CB, et al
    Variation in Treatment Patterns of Type 2 Diabetes in Older Patients.
    Diabetes Obes Metab. 2026 Aug 23. doi: 10.1111/dom.71178.
    PubMed         Abstract available
    
    
44. TANG EHM, Mak IL, Tse ETY, Yu EYT, et al
    Ten-Year Cost-Effectiveness of the Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) Relative to Usual Care in Hong Kong Public Primary Care: A Population-Based Cohort Study.
    Diabetes Obes Metab. 2026 Aug 23. doi: 10.1111/dom.71242.
    PubMed         Abstract available
    
    
45. SACOTO HD, Fonseca VA
    Hypercortisolism: An Under-Recognised Pathway Linked to Multi-System Complications.
    Diabetes Obes Metab. 2026;28 Suppl 4:60-71.
    PubMed         Abstract available
    
    
46. FRIAS JP
    Is Hypercortisolism Treatable? Which Patients Should Be Treated and How-A Practical Guide for Clinicians.
    Diabetes Obes Metab. 2026;28 Suppl 4:34-49.
    PubMed         Abstract available
    
    
47. CAVENDER MA
    Importance of Hypercortisolism in BP Control, Cardiovascular Risk and in Patients With Difficult-to-Control Hypertension: An Overview for Primary Care Physicians.
    Diabetes Obes Metab. 2026;28 Suppl 4:50-59.
    PubMed         Abstract available
    
    
48. HUANG C, Lopes A, Britton A
    Improving Short- and Long-Term Type 2 Diabetes Risk Prediction for Middle-Aged British Adults.
    Diabetes Obes Metab. 2026 Aug 26. doi: 10.1111/dom.71289.
    PubMed         Abstract available
    
    
49. WANG J, Fang H, Wang J, Cheng X, et al
    Bidirectional Association Between Diabetes and Osteoarthritis: A Population-Based Cohort Study.
    Diabetes Obes Metab. 2026 Aug 26. doi: 10.1111/dom.71286.
    PubMed         Abstract available
    
    
50. GONZALEZ A, Chastain L, Karasik O, Asmar A, et al
    Association of GLP1-Receptor Agonists With Diabetic Retinopathy.
    Diabetes Obes Metab. 2026 Aug 27. doi: 10.1111/dom.71267.
    PubMed         Abstract available
    
    
51. LIN Q, Lin Z, Ling P, Ni Y, et al
    Real-World Glycemic Outcomes of Open-Source Automated Insulin Delivery During 12 Months Among People With Type 1 Diabetes Across Age Groups.
    Diabetes Obes Metab. 2026 Aug 27. doi: 10.1111/dom.71281.
    PubMed         Abstract available
    
    
52. ZHANG B, Zhou T, Tang H, Lu Y, et al
    Comparative Effectiveness of GLP-1RAs, SGLT2is and DPP4is for Cardiovascular Outcomes in Type 2 Diabetes: An Empirically Calibrated Target Trial Emulation Study.
    Diabetes Obes Metab. 2026 Aug 27. doi: 10.1111/dom.71244.
    PubMed        
    
    
53. PIRES LV, Menezes-Santos M, Goes AC, Ribeiro HS, et al
    Exploratory Analysis of Type 2 Diabetes Mellitus Metabolic Phenotypes and Their Association With Vitamin D Status in Primary Care Patients.
    Diabetes Obes Metab. 2026 Aug 27. doi: 10.1111/dom.71275.
    PubMed         Abstract available
    
    
54. DAVE CV, Lloyd K, Nyandege A, Roy J, et al
    Increasing Trends in Hospitalisation With Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis Among Children and Youth in the United States and England, 2002-2020.
    Diabetes Obes Metab. 2026 Aug 27. doi: 10.1111/dom.71279.
    PubMed         Abstract available
    
    
55. FAUCHIER L, Guglieri M, Genet T
    Cardiovascular Risk in Type 2 Diabetes With Substance Use Disorders: Questions of Exposure and Effect Modification.
    Diabetes Obes Metab. 2026 Aug 27. doi: 10.1111/dom.71288.
    PubMed        
    
    
56. VARUGHESE MS, Nayak AU, Payne L, Varadhan L, et al
    Transitioning From Sensor-Augmented Insulin Pumps to Hybrid Closed-Loop Systems and the Risk of Progression of Diabetic Retinopathy in Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Aug 27. doi: 10.1111/dom.71290.
    PubMed        
    
    

    
    Diabetologia

57. OSTMAN M, Stordal K, Tapia G, Stene LC, et al
    Rotavirus vaccination and incidence of type 1 diabetes: a population-based natural experiment.
    Diabetologia. 2026 Aug 28. doi: 10.1007/s00125-026-06832.
    PubMed         Abstract available
    
    
58. KIM SH, Arora I, Agyemang C, Anjana RM, et al
    A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes.
    Diabetologia. 2026 Aug 26. doi: 10.1007/s00125-026-06812.
    PubMed         Abstract available
    
    
59. ESMAIL S, Hayfron-Benjamin C, Darko SN, Owusu-Dabo E, et al
    Divergent complication patterns of type 2 diabetes in African individuals who are lean versus overweight or obese: a multi-cohort analysis.
    Diabetologia. 2026 Aug 23. doi: 10.1007/s00125-026-06830.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

60. FUSTER V, Vazirani R
    Interpreting Contemporary PCI for Diabetes and Multivessel Coronary Disease After FREEDOM.
    J Am Coll Cardiol. 2026;88:828-830.
    PubMed        
    
    

    
    J Am Soc Nephrol

61. MALLIPATTU SK
    Dismissing the Chaperone in the Diabetic Kidney.
    J Am Soc Nephrol. 2026 Aug 27. doi: 10.1681/ASN.0000001237.
    PubMed        
    
    

    
    J Biol Chem

62. AL-AMILY IM, Parandeh F, Amisten S, Duner P, et al
    Increased ADORA1 expression in pancreatic islets coincides with insulin secretory defects in human type 2 diabetes.
    J Biol Chem. 2026 Aug 27:113501. doi: 10.1016/j.jbc.2026.113501.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

63. SANTOS MCF, Mamede I, Bessa R, Carvalhal G, et al
    Efficacy of sodium-glucose cotransporter 2 inhibitors after acute myocardial infarction: Are the benefits limited to patients with diabetes? A systematic review and meta-analysis.
    J Diabetes Complications. 2026;40:109393.
    PubMed         Abstract available
    
    
64. CASTUR S, Capar MU, Sahin S, Castur L, et al
    Association between SGLT-2 inhibitor use and retinal microvascular parameters in patients with Type 2 diabetes mellitus: A cross-sectional study.
    J Diabetes Complications. 2026;40:109394.
    PubMed         Abstract available
    
    
65. JANEZ A, Smid T, Rizzo M, Tankova T, et al
    Early combination therapy in type 2 diabetes: Rethinking initial treatment strategies.
    J Diabetes Complications. 2026;40:109392.
    PubMed         Abstract available
    
    

    
    J Hypertens

66. EISA N, Khoury M
    Prevalence and cardiometabolic impact of mild autonomous cortisol secretion in primary aldosteronism: a systematic review and meta-analysis.
    J Hypertens. 2026;44:1667-1676.
    PubMed         Abstract available
    
    

    
    Kidney Int

67. MOHANDES S, Nast CC, Mottl A, Scialla J, et al
    Improving the Histologic Classification of Advanced Diabetic Nephropathy Based on the Transformative Research in Diabetic Nephropathy (TRIDENT) Findings.
    Kidney Int. 2026 Aug 26:S0085-2538(26)00716-7. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    
68. YEE-MOON WANG A, Disthabanchong S, Fukami K, Jafar TH, et al
    Asia-Pacific Summit on Implementation of Clinical Practice Guidelines on Diabetes and Blood Pressure Management in Chronic Kidney Disease: A KDIGO Summit Report.
    Kidney Int. 2026 Aug 27:S0085-2538(26)00715-5. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    

    
    Metabolism

69. CHEN Y, Zhang Y, Si Q, Yu F, et al
    Beyond fibrosis: metabolic memory and cellular fate in diabetic skeletal muscle remodeling.
    Metabolism. 2026 Aug 26:156750. doi: 10.1016/j.metabol.2026.156750.
    PubMed        
    
    

    
    PLoS Med

70. ETO F, Samuel M, Stow D, Henkin R, et al
    Sex differences in trajectories to cardio-renal and mental health outcomes following the onset of type 2 diabetes: An observational cohort study using multi-state analysis in the UK Clinical Practice Research Datalink.
    PLoS Med. 2026;23:e1005196.
    PubMed         Abstract available
    
    

    
    PLoS One

71. SAID AI, Hussein M, Olet SC, Hersi AM, et al
    Occupation is a significant independent predictor of hypocalcemia among diabetic patients in Jinja, Uganda.
    PLoS One. 2026;21:e0347799.
    PubMed         Abstract available
    
    
72. 
    Expression of Concern: Determinants of medication adherence among older adults with type 2 diabetes using the health action process approach: A cross-sectional study.
    PLoS One. 2026;21:e0357069.
    PubMed        
    
    
73. 
    Correction: Artificial intelligence for early detection of diabetic retinopathy: A vision transformer-based approach.
    PLoS One. 2026;21:e0357114.
    PubMed         Abstract available
    
    
74. RORO MA, Amogne MT, Gebre MW, Rhodes EC, et al
    Adherence to gestational diabetes screening guidelines: Retrospective audit in three public hospitals in Ethiopia.
    PLoS One. 2026;21:e0357102.
    PubMed         Abstract available
    
    
75. NASIR AB, Kilani Y, Aldiabat M, Abdelghany O, et al
    Antidiabetic medications and risk of cognitive disorders in type 2 diabetes: A retrospective cohort study.
    PLoS One. 2026;21:e0356138.
    PubMed         Abstract available
    
    

    
    Retina

76. VUJOSEVIC S, Alovisi C, Gemmy Cheung CM, Fawzi A, et al
    Understanding Disorganization of Retinal Layers and the (potential) role in staging and management of Diabetic Retinal Disease.
    Retina. 2026 Aug 25. doi: 10.1097/IAE.0000000000004990.
    PubMed         Abstract available
    
    
77. HUNG CH, Chang TW
    Comment on: "Impact of GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus on the Development and Progression of Age-Related Macular Degeneration".
    Retina. 2026 Aug 25. doi: 10.1097/IAE.0000000000004994.
    PubMed        
    
    
78. MCLAUGHLIN SA, Bineshfar N, Williams BK Jr
    RE: Comment on: "Impact of GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus on the Development and Progression of Age-Related Macular Degeneration.
    Retina. 2026 Aug 25. doi: 10.1097/IAE.0000000000004995.
    PubMed        
    
    

    
    Transplantation

79. HARADA M, Takeda K, Tsuji-Yogo K, Morimoto K, et al
    Regulatory T Cells Allosensitized Under the Blockade of CD80/CD86-CD28 Costimulation Prolonged Islet Allograft Survival.
    Transplantation. 2026;110:e1805-e1814.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum